Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption Authors Fabrice André (ORCID: https://orcid.org/0000-0001-5795-8357) François‐Clément Bidard (ORCID: https://orcid.org/0000-0001-5932-8949) Romain Loyon (ORCID: https://orcid.org/0000-0001-8039-7893) Julien Viot (ORCID: https://orcid.org/0000-0001-7792-0110) Sylvain Ladoire (ORCID: https://orcid.org/0000-0002-0331-9194) Amélie Marguier (ORCID: https://orcid.org/0000-0002-5649-6688) Evan Seffar (ORCID: https://orcid.org/0000-0002-2185-5548) Romain Boidot (ORCID: https://orcid.org/0000-0001-9956-1737) Elsa Curtit (ORCID: https://orcid.org/0000-0003-4814-8680) Laurie Spehner (ORCID: https://orcid.org/0000-0002-4126-5553) Valentin Dérangère (ORCID: https://orcid.org/0000-0002-6311-5628) Erion Dobi Guillaume Meynard (ORCID: https://orcid.org/0000-0002-0646-4055) Marie Kroemer (ORCID: https://orcid.org/0000-0001-9274-619X) Christophe Borg (ORCID: https://orcid.org/0000-0002-2167-1458) Laura Mansi (ORCID: https://orcid.org/0000-0001-6079-5085) Morgane Lopez Institutions Memorial Sloan Kettering Cancer Center (US) Inserm (FR) Université de Bourgogne (FR) Université Paris Sciences et Lettres (FR) Université Paris-Saclay (FR) Institut Gustave Roussy (FR) Centre Hospitalier Universitaire de Besançon (FR) Centre Georges François Leclerc (FR) Institut Curie (FR) Université de Franche-Comté (FR) Explore the Global Research Space Interactive Map